Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor markers for endocrine neoplasms].

T Okamoto1

  • 1Department of Endocrine Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 2, 2001
PubMed
Summary

Thyroid cancer diagnosis and management rely on specific tumor markers like thyroglobulin, calcitonin, and CEA. These markers aid in distinguishing benign from malignant tumors and monitoring patients post-surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel ubiquinone reductase activity in rat cytosol.

FEBS letters·1992
Same author

[Clinical studies on cefprozil in pediatrics].

The Japanese journal of antibiotics·1992
Same author

Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201-995.

International journal of colorectal disease·1992
Same author

Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism.

Surgery·1992
Same author

[Effects of magnesium and calcium on muscle contractility and neuromuscular blockade produced by muscle relaxants and aminoglycoside].

Masui. The Japanese journal of anesthesiology·1992
Same author

Gastric volvulus complicating myotonic dystrophy.

Hepato-gastroenterology·1992

Area of Science:

  • Oncology
  • Biochemistry
  • Endocrinology

Context:

  • Thyroid and parathyroid neoplasms present diagnostic challenges.
  • Accurate tumor markers are crucial for effective patient management.
  • Current diagnostic strategies require refinement for specific cancer types.

Purpose:

  • To review the utility of established tumor markers for thyroid neoplasms.
  • To discuss the role of thyroglobulin, calcitonin, and CEA in diagnosis and follow-up.
  • To highlight the lack of specific markers for parathyroid carcinoma and alternative diagnostic approaches.

Summary:

  • Thyroglobulin aids in differentiating follicular thyroid carcinoma from benign conditions and in postoperative surveillance for follicular and papillary carcinomas.
  • Plasma calcitonin and CEA are vital for diagnosing and managing medullary thyroid carcinoma, with genetic tests emerging for familial cases.
  • Parathyroid carcinoma lacks specific tumor markers, necessitating reliance on clinical characteristics for diagnosis.

Impact:

  • Improved diagnostic accuracy for thyroid neoplasms.
  • Enhanced postoperative monitoring strategies for thyroid cancer patients.
  • Informed clinical decision-making in the absence of specific parathyroid cancer biomarkers.

Related Experiment Videos